No inconsistent trial assessments by NICE and IQWiG: different assessment goals may lead to different assessment results regarding subgroup analyses

J Clin Epidemiol. 2010 Dec;63(12):1305-7. doi: 10.1016/j.jclinepi.2010.06.003. Epub 2010 Oct 6.

Authors

Ralf Bender¹, Armin Koch, Guido Skipka, Thomas Kaiser, Stefan Lange

Affiliation

¹ Department of Medical Biometry, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany. ralf.bender@iqwig.de

PMID: 20926256
DOI: 10.1016/j.jclinepi.2010.06.003

No abstract available

Publication types

Comment

MeSH terms

Aspirin / therapeutic use
Cardiovascular Diseases / drug therapy
Cardiovascular Diseases / prevention & control*
Clopidogrel
England
Evidence-Based Medicine / standards*
Germany
Humans
Prescription Drugs
Randomized Controlled Trials as Topic*
Research Design
Ticlopidine / analogs & derivatives
Ticlopidine / therapeutic use

Substances

Prescription Drugs
Clopidogrel
Ticlopidine
Aspirin